Skip to main content
Scott Furlan, MD, Pediatric Hematology & Oncology, Seattle, WA, Seattle Children's Hospital

ScottNicholasFurlanMD

Pediatric Hematology & Oncology Seattle, WA

Assistant Professor

Dr. Furlan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Furlan's full profile

Already have an account?

Summary

  • Dr. Scott Furlan is a pediatric hematologist/oncologist at the Fred Hutchinson Cancer Center in Seattle, WA and is affiliated with Seattle Children's Hospital. He received his medical degree from University of Southern California School of Medicine and has been in practice 15 years. He is experienced in transplant immunology, tumor immunology, adoptive immunotherapy, omics, and regulatory t-lymphocytes. He has more than 20 publications and over 500 citings.

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2009 - 2012
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Pediatrics, 2006 - 2009
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - Present
  • WA State Medical License
    WA State Medical License 2013 - 2026
  • TX State Medical License
    TX State Medical License 2008 - 2013
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Lectures

  • IL2 and Rapamycin Enhance Persistence of Adoptively-Transferred Ex-Vivo Expanded T Regulatory Cells 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Pharmacologic Blockade of Notch/Delta-like Ligand 4 Signaling Protects from Gastrointestinal Acute Graft-Versus-Host Disease in Non-Human Primates 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • BBI Funds ‘Entirely Novel Approach’ to Studying Pediatric Leukemia
    BBI Funds ‘Entirely Novel Approach’ to Studying Pediatric LeukemiaFebruary 28th, 2022

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations